187 related articles for article (PubMed ID: 31182716)
1. Structural insights into substrate recognition by the SOCS2 E3 ubiquitin ligase.
Kung WW; Ramachandran S; Makukhin N; Bruno E; Ciulli A
Nat Commun; 2019 Jun; 10(1):2534. PubMed ID: 31182716
[TBL] [Abstract][Full Text] [Related]
2. Biophysical studies on interactions and assembly of full-size E3 ubiquitin ligase: suppressor of cytokine signaling 2 (SOCS2)-elongin BC-cullin 5-ring box protein 2 (RBX2).
Bulatov E; Martin EM; Chatterjee S; Knebel A; Shimamura S; Konijnenberg A; Johnson C; Zinn N; Grandi P; Sobott F; Ciulli A
J Biol Chem; 2015 Feb; 290(7):4178-91. PubMed ID: 25505247
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the SOCS2-elongin C-elongin B complex defines a prototypical SOCS box ubiquitin ligase.
Bullock AN; Debreczeni JE; Edwards AM; Sundström M; Knapp S
Proc Natl Acad Sci U S A; 2006 May; 103(20):7637-42. PubMed ID: 16675548
[TBL] [Abstract][Full Text] [Related]
4. The SOCS2 ubiquitin ligase complex regulates growth hormone receptor levels.
Vesterlund M; Zadjali F; Persson T; Nielsen ML; Kessler BM; Norstedt G; Flores-Morales A
PLoS One; 2011; 6(9):e25358. PubMed ID: 21980433
[TBL] [Abstract][Full Text] [Related]
5. Serendipitous SAD Solution for DMSO-Soaked SOCS2-ElonginC-ElonginB Crystals Using Covalently Incorporated Dimethylarsenic: Insights into Substrate Receptor Conformational Flexibility in Cullin RING Ligases.
Gadd MS; Bulatov E; Ciulli A
PLoS One; 2015; 10(6):e0131218. PubMed ID: 26121586
[TBL] [Abstract][Full Text] [Related]
6. A growth hormone receptor SNP promotes lung cancer by impairment of SOCS2-mediated degradation.
Chhabra Y; Wong HY; Nikolajsen LF; Steinocher H; Papadopulos A; Tunny KA; Meunier FA; Smith AG; Kragelund BB; Brooks AJ; Waters MJ
Oncogene; 2018 Jan; 37(4):489-501. PubMed ID: 28967904
[TBL] [Abstract][Full Text] [Related]
7. Structure of the SOCS4-ElonginB/C complex reveals a distinct SOCS box interface and the molecular basis for SOCS-dependent EGFR degradation.
Bullock AN; Rodriguez MC; Debreczeni JE; Songyang Z; Knapp S
Structure; 2007 Nov; 15(11):1493-504. PubMed ID: 17997974
[TBL] [Abstract][Full Text] [Related]
8. Discovery of an exosite on the SOCS2-SH2 domain that enhances SH2 binding to phosphorylated ligands.
Linossi EM; Li K; Veggiani G; Tan C; Dehkhoda F; Hockings C; Calleja DJ; Keating N; Feltham R; Brooks AJ; Li SS; Sidhu SS; Babon JJ; Kershaw NJ; Nicholson SE
Nat Commun; 2021 Dec; 12(1):7032. PubMed ID: 34857742
[TBL] [Abstract][Full Text] [Related]
9. SOCS2 Binds to and Regulates EphA2 through Multiple Mechanisms.
Pilling C; Cooper JA
Sci Rep; 2017 Sep; 7(1):10838. PubMed ID: 28883622
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for c-KIT inhibition by the suppressor of cytokine signaling 6 (SOCS6) ubiquitin ligase.
Zadjali F; Pike AC; Vesterlund M; Sun J; Wu C; Li SS; Rönnstrand L; Knapp S; Bullock AN; Flores-Morales A
J Biol Chem; 2011 Jan; 286(1):480-90. PubMed ID: 21030588
[TBL] [Abstract][Full Text] [Related]
11. Structure-based design of a phosphotyrosine-masked covalent ligand targeting the E3 ligase SOCS2.
Ramachandran S; Makukhin N; Haubrich K; Nagala M; Forrester B; Lynch DM; Casement R; Testa A; Bruno E; Gitto R; Ciulli A
Nat Commun; 2023 Oct; 14(1):6345. PubMed ID: 37816714
[TBL] [Abstract][Full Text] [Related]
12. Multifaceted N-Degron Recognition and Ubiquitylation by GID/CTLH E3 Ligases.
Chrustowicz J; Sherpa D; Teyra J; Loke MS; Popowicz GM; Basquin J; Sattler M; Prabu JR; Sidhu SS; Schulman BA
J Mol Biol; 2022 Jan; 434(2):167347. PubMed ID: 34767800
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for the recognition of N-end rule substrates by the UBR box of ubiquitin ligases.
Choi WS; Jeong BC; Joo YJ; Lee MR; Kim J; Eck MJ; Song HK
Nat Struct Mol Biol; 2010 Oct; 17(10):1175-81. PubMed ID: 20835240
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for phosphotyrosine recognition by suppressor of cytokine signaling-3.
Bergamin E; Wu J; Hubbard SR
Structure; 2006 Aug; 14(8):1285-92. PubMed ID: 16905102
[TBL] [Abstract][Full Text] [Related]
15. Crystallization and preliminary X-ray analysis of the splice variant of human ankyrin repeat and suppressor of cytokine signaling box protein 9 (hASB9-2).
Fei X; Zhang Y; Gu X; Qiu R; Mao Y; Ji C
Protein Pept Lett; 2009; 16(3):333-5. PubMed ID: 19275750
[TBL] [Abstract][Full Text] [Related]
16. The many faces of the SOCS box.
Piessevaux J; Lavens D; Peelman F; Tavernier J
Cytokine Growth Factor Rev; 2008; 19(5-6):371-81. PubMed ID: 18948053
[TBL] [Abstract][Full Text] [Related]
17. Unbiased identification of substrates for the Epac1-inducible E3 ubiquitin ligase component SOCS-3.
Williams JJ; Palmer TM
Biochem Soc Trans; 2012 Feb; 40(1):215-8. PubMed ID: 22260693
[TBL] [Abstract][Full Text] [Related]
18. Structural analysis of the LDL receptor-interacting FERM domain in the E3 ubiquitin ligase IDOL reveals an obscured substrate-binding site.
Martinelli L; Adamopoulos A; Johansson P; Wan PT; Gunnarsson J; Guo H; Boyd H; Zelcer N; Sixma TK
J Biol Chem; 2020 Sep; 295(39):13570-13583. PubMed ID: 32727844
[TBL] [Abstract][Full Text] [Related]
19. The substrate binding domains of human SIAH E3 ubiquitin ligases are now crystal clear.
Zhang Q; Wang Z; Hou F; Harding R; Huang X; Dong A; Walker JR; Tong Y
Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3095-3105. PubMed ID: 27776223
[TBL] [Abstract][Full Text] [Related]
20. Recognition of substrate degrons by E3 ubiquitin ligases and modulation by small-molecule mimicry strategies.
Lucas X; Ciulli A
Curr Opin Struct Biol; 2017 Jun; 44():101-110. PubMed ID: 28130986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
